K. Travers

发表

Review of assessments of the human health risk associated with the use of antimicrobial agents in agriculture.

J. Bailar, K. Travers, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Humanistic Burden of Head and Neck Cancer: A Systematic Literature Review

C. Pashos, I. Griebsch, K. Travers, 2014, PharmacoEconomics.

Disease Burden and management of chronic kidney disease in Japan : systematic review of the literature

K. Boye, K. Travers, Lauren J. Lee, 2012 .

The Effectiveness and Value of Palliative Care in the Outpatient Setting

D. Ollendorf, K. Travers, C. Cunningham, 2017, JAMA internal medicine.

Clusters of lymphoma in ferrets.

S. Badylak, J. Fox, S. A. Brown, 1996, Cancer investigation.

Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey

S. Walzer, K. Travers, D. Matusiewicz, 2013, ClinicoEconomics and outcomes research : CEOR.

HIV Antibody Detection in Serum

K. Travers, P. Kanki, 1990 .

Real-world adverse events with niraparib 200 mg/day maintenance therapy in ovarian cancer: a retrospective study.

S. Westin, B. Harrow, K. Travers, 2019, Future oncology.

Natural protection against HIV-1 infection provided by HIV-2.

I. Thior, S. Mboup, J. Sankalé, 1995, Science.

Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial

R. Wenham, J. Ledermann, F. Marmé, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PGI5 Irritable Bowel Syndrome with Constipation (IBS-C): A European-Focused Systematic Literature Review of Disease Burden

K. Travers, T. Foster, M. Prior, 2011 .

Excess infections due to antimicrobial resistance: the "Attributable Fraction".

K. Travers, M. Barza, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Morbidity of infections caused by antimicrobial-resistant bacteria.

K. Travers, M. Barza, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reduced rate of disease development after HIV-2 infection as compared to HIV-1.

I. Thior, C. Hsieh, S. Mboup, 1994, Science.

Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2.

S. Popper, S. Mboup, M. Essex, 1999, The Journal of infectious diseases.

Slower heterosexual spread of HIV-2 than HIV-1

I. Thior, C. Hsieh, S. Mboup, 1994, The Lancet.

Framework for Use of Antimicrobial Resistance Surveillance in the Development of Standard Treatment Guidelines Prepared by The Alliance for the Prudent Use of Antibiotics

S. Levy, K. Travers, T. O'Brien, 2003 .

Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype.

S. Mboup, J. Sankalé, M. Essex, 2000, Virology.

Plasma RNA viral load as measured by the branched DNA and nucleic acid sequence-based amplification assays of HIV-1 subtypes A and D in Uganda.

B. Walker, A. Caliendo, D. Hom, 1999, Journal of acquired immune deficiency syndromes.

Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in west African female prostitutes.

W Leisenring, W. Leisenring, I. Thior, 1992, American journal of epidemiology.

Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa.

S. Mboup, C. Boye, R. Marlink, 1987, Science.

Integrating Escherichia coli Antimicrobial Susceptibility Data from Multiple Surveillance Programs

Ronald N. Jones, S. Levy, T. O'Brien, 2005, Emerging infectious diseases.

Burden and management of chronic kidney disease in Japan: systematic review of the literature

K. Boye, K. Travers, Lauren J. Lee, 2013, International journal of nephrology and renovascular disease.

Characteristics and temporal trends in patient registries: focus on the life sciences industry, 1981–2012

B. Luce, C. Pashos, M. Beattie, 2014, Pharmacoepidemiology and drug safety.

A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation

M. Dimopoulos, N. Abildgaard, T. Facon, 2017, Leukemia & lymphoma.

Humanistic and economic burden of generalized anxiety disorder in North America and Europe.

D. Sheehan, D. Revicki, K. Wyrwich, 2012, Journal of affective disorders.

Major depressive disorder in Africa and the Middle East: a systematic literature review

K. Travers, S. Cadarette, J. Mould, 2013, Expert review of pharmacoeconomics & outcomes research.

Budget impact of niraparib as maintenance treatment in recurrent ovarian cancer following platinum-based chemotherapy.

B. Harrow, K. Travers, L. Stern, 2019, Journal of comparative effectiveness research.

Budget impact analysis of niraparib for first-line maintenance therapy in advanced ovarian cancer from a US payer perspective

J. Hurteau, K. Travers, Jinan Liu, 2021, Journal of managed care & specialty pharmacy.

Protection from HIV-1 infection by HIV-2.

C. Hsieh, S. Mboup, M. Essex, 1998, AIDS.

HIV-2 and Natural Protection Against HIV-1 Infection

H. Jaffe, C. Hsieh, S. Mboup, 1996, Science.